Soc. Generale Call 42 ABBN 21.06..../ DE000SU2FGK4 /
13/05/2024 13:29:55 | Diferencia+0.080 | Bid14:16:18 | Ask14:16:18 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.560EUR | +16.67% | 0.570 Volumen de oferta: 150,000 |
0.580 Tamaño/ Volumen/ Formato de Ask: 150,000 |
ABB LTD N | 42.00 CHF | 21/06/2024 | Call |
GlobeNewswire
14:15
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of ...
GlobeNewswire
14:15
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
14:05
Company Name Change to NAPC Defense, Inc. (OTCPK: BLIS) and Website to NAPCDefense.com among Busines...
GlobeNewswire
14:05
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire
14:05
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Results and Provides Corporate Upda...
GlobeNewswire
14:03
Tango Launches Global Choice Link, making it easy and awesome for businesses to deliver rewards, inc...
GlobeNewswire
14:02
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2024 Earnings Release Confere...
GlobeNewswire
14:01
SecureW2 Wins Digital Certificate, Network Security, and Passwordless Solution Categories in 2024 Cy...
GlobeNewswire
14:00
SOUTHERN CALIFORNIA BANCORP AND CALIFORNIA BANCORP ANNOUNCE RECEIPT OF REGULATORY APPROVAL FOR MERGE...
GlobeNewswire
14:00
X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire
14:00
Great Pacific Gold Reports Multiple High-Grade Gold Assays from Kesar Creek Project in Papua New Gui...
GlobeNewswire
14:00
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Present...
GlobeNewswire
14:00
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página